Management of nonsteroidal anti-inflammatory drug-related peptic ulcer bleeding

American Journal of Medicine

Volumn 110, Issue 1 SUPPL. 1, 2001, Pages S29-S32

  Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BISMUTH CITRATE; METRONIDAZOLE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; TETRACYCLINE;

ANALGESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; PAIN; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH ACID SECRETION; STOMACH PROTECTION;

EID: 0035825164     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00633-1     Document Type: Review

References (5)

1. Time trend analysis of peptic ulcer bleeding over an 8-year period in Hong Kong
2. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomised study
3. Randomized controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs
4. Prospective randomized trial of H. pylori eradication versus maintenance omeprazole to prevent recurrent upper gastrointestinal hemorrhage in high-risk aspirin and nonaspirin-NSAID users
5. Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent upper recurrent gastrointestinal hemorrhage in users of nonsteroidal anti-inflammatory drugs